Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe (Q42258745)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 June 2013

Language	Label	Description	Also known as
English	Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe	scientific article published on 13 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

0 references

Epstein–Barr virus

0 references

27

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Miguel Angel Diaz

object named as

Miguel A Diaz

18

0 references

Rafael de la Camara

object named as

Rafael de la Camara

22

0 references

object named as

Franca Fagioli

16

0 references

4

object named as

Per Ljungman

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hermann Einsele

26

object named as

Hermann Einsele

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jan Styczyński

1

object named as

Jan Styczynski

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2

object named as

Lidia Gil

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Krzysztof Kałwak

12

object named as

Krzysztof Kalwak

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Gloria Tridello

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J Peter Donnelly

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Walter van der Velden

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hamdy Omar

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Rodrigo Martino

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Constantijn Halkes

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Maura Faraci

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Koen Theunissen

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Petr Hubacek

13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Simona Sica

14

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Chiara Nozzoli

15

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Susanne Matthes

17

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Maddalena Migliavacca

19

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Adriana Balduzzi

20

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Agnieszka Tomaszewska

21

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Anja van Biezen

23

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jennifer Hoek

24

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Simona Iacobelli

25

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

28

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

13 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

794-802

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

A prospective study on modulation of immunosuppression for Epstein-Barr virus reactivation in pediatric patients who underwent unrelated hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

The real-time polymerase chain reaction-guided modulation of immunosuppression enables the pre-emptive management of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Rituximab reduces the incidence of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT391

21 January 2018

Identifiers

10.1093/CID/CIT391

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42258745&oldid=1776789618"